Intermittent Liposomal Amphotericin B Primary Prophylaxis

PHASE2UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2007

Study Completion Date

October 31, 2014

Conditions
Acute Myeloid Leukemia
Interventions
DRUG

Liposomal amphotericin B

Trial Locations (2)

3004

NOT_YET_RECRUITING

The Alfred Hosptial, Melbourne

3129

RECRUITING

Box Hill Hospital, Eastern Health, Melbourne

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

Bayside Health

OTHER_GOV